Text Message Quit Vaping Intervention for Adolescents

February 16, 2023 updated by: Truth Initiative
This research study, conducted by Truth Initiative, will help us learn how text messaging can help adolescents between 13 and 17 years of age quit vaping.

Study Overview

Detailed Description

The Teen Quit Vaping Study (QVS Teen) is a comparative effectiveness trial to evaluate the effectiveness of a quit vaping text message program in promoting abstinence from e-cigarettes among young users aged 13-17. This study is a 3-arm randomized controlled trial conducted among young users aged 13-17 recruited through online channels. Participants will be randomized to a quit vaping text message intervention, an assessment-only control condition, or a waitlist control condition. The primary aim is to examine 30-day point prevalence abstinence at 7-months post enrollment (roughly corresponds to 6-months post-treatment).

Study Type

Interventional

Enrollment (Actual)

1715

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • District of Columbia
      • Washington, District of Columbia, United States, 20001
        • Truth Initiative

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 17 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 13-17
  • Past 30-day use of e-cigarettes containing nicotine
  • Interest in quitting e-cigarette use in the next 30 days
  • US residence

Exclusion Criteria:

  • Failure to confirm mobile number after initial sign-up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: This is Quitting

Participants will be enrolled to receive messages from This is Quitting.

Users receive one age-appropriate message per day tailored to their enrollment date or quit date, which can be set and reset via text message. Those not ready to quit receive 4 weeks of messages focused on building skills and confidence. Users who set a quit date receive messages for a week preceding it and 8 weeks afterward that include encouragement and support, skill- and self-efficacy building exercises, coping strategies, and information about the risks of vaping, benefits of quitting, and cutting down to quit. Keywords COPE, STRESS, SLIP, and MORE provide on-demand support.

Text message-based intervention for quit vaping support.
Other: Assessment only control
After an initial enrollment message, participants will be contacted monthly to assess e-cigarette use. At the end of the study data collection period, they will receive information on how to sign up for This is Quitting if they are interested in the program.
Assessment only
Other: Waitlist control
After an initial enrollment message, participants will receive no contact from study staff except for 1-month and 7-month follow-up assessments. At the end of the study data collection period, they will receive information on how to sign up for This is Quitting if they are interested in the program.
No contact until follow-up survey, waitlisted to receive intervention post study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported 30-day Point Prevalence Abstinence
Time Frame: 7 months post enrollment
In the past 30 days, did you vape at all, even a puff of someone else's?
7 months post enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30-day Point Prevalence Abstinence
Time Frame: 1 month post enrollment
In the past 30 days, did you vape at all, even a puff of someone else's?
1 month post enrollment
Number of Quit Attempts
Time Frame: 1 and 7 months post enrollment
Since you joined the study a month ago/In the last 6 months, how many times have you stopped vaping - not even a puff - for one day or longer because you were trying to quit for good?
1 and 7 months post enrollment
Changes in Daily E-cigarette Use Frequency
Time Frame: 1 and 7 months post enrollment
On average, how many puffs/hits on your vape do you take on a typical day?
1 and 7 months post enrollment
Changes in Confidence in Quitting E-cigarettes
Time Frame: 1 and 7 months post enrollment
How confident are you that you can quit vaping? Response on a scale of 1-5
1 and 7 months post enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2021

Primary Completion (Anticipated)

October 15, 2023

Study Completion (Anticipated)

October 15, 2023

Study Registration Dates

First Submitted

June 4, 2021

First Submitted That Met QC Criteria

June 4, 2021

First Posted (Actual)

June 9, 2021

Study Record Updates

Last Update Posted (Estimate)

February 20, 2023

Last Update Submitted That Met QC Criteria

February 16, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • TruthInitiativeQVSTeen

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD are not available to other researchers. For access to deidentified dataset, please contact study administrator for more information.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vaping

Clinical Trials on This is Quitting

3
Subscribe